|
Product Details:
|
| Product Name: | Huperzine A | Other Name: | SELAGINE |
|---|---|---|---|
| CAS No: | 120786-18-7 | MF: | C15H18N2O |
| MW: | 242.32 | Purity: | 1% |
| Shelf Life: | 2 Years | Application: | Pharmaceutical API |
| Sample: | Available | Storage: | Cool And Dry Place |
| High Light: | 1% Nootropics Powder CAS 120786-18-7,CAS 120786-18-7 Huperzine A Powder,1% Purity Nootropics Powder |
||
1% Purity Plant Extract Nootropics Powder CAS 120786-18-7 Huperzine A
Product Introduction
| Name | Huperzine A |
| English synonyms | SELAGINE |
| CAS Number | 120786-18-7 |
| Molecular formula | C15H18N2O |
| Molecular weight | 242.32 |
| EINECS number | / |
Product Description
| Melting point | / |
| Specific Rotation | / |
| Optical Activity | / |
| Boiling point | 505.0±50.0 °C(Predicted) |
| Density | 1.20±0.1 g/cm3(Predicted) |
| Refractive Index | / |
| Solubility | / |
| Storage | 2-8°C |
| Acidity coefficient (pKa) | 12.25±0.60(Predicted) |
| Appearance | Off-white solid. |
Product Function
Huperzine A has been proven superior to drugs licensed for the treatment of Alzheimer's, including the leading anticholine sterase drugs physostigmine and tacrine. Huperzine A improved learning and memory in mice better than tacrine. Unlike physostigmine and tacrine, Huperzine A acts specifically on AchE in the brain rather than AchE found elsewhere in the body i.e., far less is wasted on irrelevant effects. Unlike physostigmine and tacrine, Huperzine A does not appear to bind to receptors in the central nervous system, which can cause adverse side effects. Its effects last 10 to 12 times longer than physostigmine and tacrine (up to 8 hours).
Contact Person: Mrs. Angie Zhang
Tel: +8613627115097
Fax: 86-27-5970-7018
